Search results
By picking J.D. Vance for VP, Trump doubles down on Trumpism
ABC News via Yahoo Canada News· 3 hours agoJ.D. Vance of Ohio will be his running mate in the 2024 presidential election. Vance’s selection...
MPLX vs. WMB: Which Stock Is the Better Value Option?
Zacks via Yahoo Finance Canada· 5 days agoAnother notable valuation metric for MPLX is its P/B ratio of 3.25. Investors use the P/B ratio to...
Thomas Hoepker, Who Captured an Indelible 9/11 Image, Dies at 88
New York Times· 2 days agoOn the morning of Sept. 11, 2001, the photographer Thomas Hoepker was following the instincts of a...
West Arunta niobium hits keep coming for Encounter
Business News· 24 hours agoLooking at a different commodity, the thickness and grade of a niobium hit reported by Encounter Resources may not seem spectacular, but it is notable in a unique target.
Survey shows 15% of Montreal tenants have experienced homelessness
Montreal Gazette· 5 days agoAround 15 per cent of Montreal tenants report having experienced an episode of homelessness at some...
Lomiko Metals Provides an Update on Closing of the Flow-Through Unit Offering and Closing of the...
Financial Post· 16 hours agoLomiko Metals Inc. (TSX.V: LMR) (“Lomiko Metals” or the “Company”) is pleased to announce that following the effective date of the previously announced share consolidation update (“Consolidation ...
New Found Completes Acquisition of Labrador Gold's Kingsway Project
Financial Post· 7 days agoPursuant to the Acquisition, New Found has issued to LabGold 5,263,157 common shares as consideration for the Purchased Assets. New Found holds a 100% interest in the Queensway Project, located ...
Rupert Resources Reports Results for the Three Months Ending May 31, 2024
Financial Post· 4 days agoRupert Resources Ltd (“Rupert” or the “Company”) announces that it has published its unaudited financial results for the three months ending May 31, 2024 and accompanying Management’s Discussion ...
Sensorion Announces New Positive Secondary Efficacy Endpoints Data From SENS-401 Phase 2a Clinical...
Financial Post· 24 hours agoALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today ...
Yevgen Balter is revealing the insights and challenges of top-tier managers
TechBullion· 10 hours agoYevgen Balter is responsible for the growth and development of effective, geo-distributed,...